Drugs / IL-13 Rα2 UCAR-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05752877 | May 2021 → Apr 2026 | glioma | Second Affiliated Hospital of Soochow University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IL-13 Rα2 UCAR-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05752877 ↗ |
| Modality | Cell therapy | “Targeted IL-13 Rα2 UCAR-T cell injection” NCT05752877 ↗ |
| Route | Other | “local administration (intracranial cavity or intravertebral injection after surgery)” NCT05752877 ↗ |